• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

BioN­Tech opens the hood on its AI am­bi­tions, and they're not just for mR­NA

7 months ago
R&D
AI

As­traZeneca, Ab­b­Vie, PhRMA lose court bat­tle over Louisiana 340B law

7 months ago
Pharma
FDA+

Gilead li­cens­es HIV shot to six gener­ic man­u­fac­tur­ers, but falls short of ac­cess sought by ad­vo­cates

7 months ago
Pharma
Manufacturing

EMA looks to make its drug ap­proval process­es more ef­fi­cient

7 months ago
FDA+

J&J bud­gets over $2B for new North Car­oli­na bi­o­log­ics fa­cil­i­ty

7 months ago
Pharma
Manufacturing

A blow to Hu­mana’s Medicare Ad­van­tage qual­i­ty rat­ings could tank its rev­enue by bil­lions

7 months ago
Health Tech

Teladoc COO re­signs amid ex­ec­u­tive shuf­fle

7 months ago
People
Health Tech

Wave’s new cap­i­tal ex­tends cash run­way in­to 2027, CEO says

7 months ago
R&D

Fra­zier adds $630M to pub­lic fund to 'take ad­van­tage of mar­ket volatil­i­ty'

7 months ago
Financing

Scoop: Found­ing CEO leaves Atom­wise, cast­ing doubt over a once high-fly­ing AI start­up 

7 months ago
People
AI

Ex­clu­sive: Medicare nav­i­ga­tion start­up Con­nie Health is buy­ing a Re­design Health-backed ri­val

7 months ago
Deals
Health Tech

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

7 months ago
R&D
Pharma

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

7 months ago
Startups
AI

Triveni to take ex­per­i­men­tal eczema drug to the clin­ic, backed by new $115M fi­nanc­ing round

7 months ago
Financing
Startups

UK biotech bags $43M in Se­ries A to move Hunt­ing­ton's drug in­to first hu­man study

7 months ago
Financing
R&D

GSK’s Vi­iV stops de­vel­op­ment of Phase 2 HIV an­tivi­ral

7 months ago
R&D
Pharma

Up­dat­ed: Sen­a­tors ques­tion FDA and FTC over patent and PBM re­forms

7 months ago
FDA+
Law

Judge keeps Am­gen's $10.7B tax li­a­bil­i­ty suit alive 

7 months ago
Pharma
Law

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

7 months ago
People
Pharma

Bio­haven aims to raise $250M; Ac­tivist in­vestor's stake in Gala­pa­gos ex­ceeds 10%

7 months ago
News Briefing

Tar­get­ing No­var­tis' Scem­blix, En­liv­en lays out case for leukemia drug in ear­ly re­sults

7 months ago
R&D

Grit­stone bio’s stock dips af­ter it shares more da­ta from failed Phase 2 col­orec­tal can­cer tri­al

7 months ago
R&D

CAMP4, prepar­ing for IPO, an­nounces part­ner­ship with Bio­Marin

7 months ago
Startups
Deals

CVS con­sid­ers break­ing up the com­pa­ny as in­vestors urge turn­around — re­ports

7 months ago
Health Tech
First page Previous page 87888990919293 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times